Published in Emerg Infect Dis on May 01, 2013
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans. PLoS Curr (2013) 3.41
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet (2013) 3.40
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio (2014) 2.50
Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol (2013) 1.76
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A (2014) 1.54
Group C betacoronavirus in bat guano fertilizer, Thailand. Emerg Infect Dis (2013) 1.47
Middle East Respiratory Syndrome Coronavirus Intra-Host Populations Are Characterized by Numerous High Frequency Variants. PLoS One (2016) 1.42
Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio (2013) 1.34
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother (2014) 1.34
Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus KOR/KNIH/002_05_2015, Isolated in South Korea. Genome Announc (2015) 1.27
The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis (2014) 1.14
Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis (2014) 1.13
Identification of new respiratory viruses in the new millennium. Viruses (2015) 1.09
MERS coronavirus: diagnostics, epidemiology and transmission. Virol J (2015) 1.01
From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis (2013) 0.96
Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting. J Virol (2014) 0.94
Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease. Virology (2015) 0.93
FASconCAT-G: extensive functions for multiple sequence alignment preparations concerning phylogenetic studies. Front Zool (2014) 0.92
Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. MBio (2014) 0.92
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep (2016) 0.91
MERS-CoV: Bridging the Knowledge Gaps. Oman Med J (2014) 0.89
Emergence of the Middle East respiratory syndrome coronavirus. PLoS Pathog (2013) 0.86
MERS-CoV: the intermediate host identified? Lancet Infect Dis (2013) 0.86
Autologous antibody capture to enrich immunogenic viruses for viral discovery. PLoS One (2013) 0.86
Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. MBio (2016) 0.85
Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing. J Virol (2015) 0.85
Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). PLoS One (2015) 0.83
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev (2017) 0.83
Tracing the SARS-coronavirus. J Thorac Dis (2013) 0.82
Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi. Emerg Infect Dis (2016) 0.82
The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci Rep (2016) 0.81
A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design. BMC Bioinformatics (2014) 0.81
OASes and STING: adaptive evolution in concert. Genome Biol Evol (2015) 0.81
Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV). BMC Res Notes (2014) 0.80
Pathosphere.org: pathogen detection and characterization through a web-based, open source informatics platform. BMC Bioinformatics (2015) 0.80
Laboratory investigation and phylogenetic analysis of an imported Middle East respiratory syndrome coronavirus case in Greece. PLoS One (2015) 0.78
Unraveling the mysteries of Middle East respiratory syndrome coronavirus. Emerg Infect Dis (2014) 0.78
A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj. Risk Anal (2014) 0.77
Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak. J Korean Med Sci (2016) 0.77
Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud (2016) 0.75
Emerging infections - implications for dental care. Br Dent J (2016) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res (2008) 151.16
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol (2010) 53.37
Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol (2012) 32.00
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (2003) 12.59
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 8.54
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill (2012) 7.96
Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill (2012) 4.96
Using the Velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics (2010) 4.88
Molecular diversity of coronaviruses in bats. Virology (2006) 3.98
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Prevalence and genetic diversity of coronaviruses in bats from China. J Virol (2006) 3.37
Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis (2010) 2.65
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
Viral population analysis and minority-variant detection using short read next-generation sequencing. Philos Trans R Soc Lond B Biol Sci (2013) 2.33
Detection of alpha and betacoronaviruses in multiple Iberian bat species. Arch Virol (2011) 1.95
Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology (2007) 1.89
Evidence supporting a zoonotic origin of human coronavirus strain NL63. J Virol (2012) 1.75
Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol (2011) 1.60
Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol (2006) 1.40
SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission. Curr Opin Virol (2011) 1.15
The application of genomics to emerging zoonotic viral diseases. PLoS Pathog (2009) 1.12
Severe acute respiratory syndrome coronavirus sequence characteristics and evolutionary rate estimate from maximum likelihood analysis. J Virol (2004) 1.07
Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol (2004) 1.00
Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses. Infect Genet Evol (2009) 0.93
BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol (2007) 74.13
Relaxed phylogenetics and dating with confidence. PLoS Biol (2006) 37.68
Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol (2012) 32.00
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Estimating the rate of intersubtype recombination in early HIV-1 group M strains. J Virol (2012) 12.78
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Bayesian phylogeography finds its roots. PLoS Comput Biol (2009) 10.99
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol (2005) 8.42
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One (2009) 8.37
Unifying the epidemiological and evolutionary dynamics of pathogens. Science (2004) 8.33
Rise and fall of the Beringian steppe bison. Science (2004) 7.91
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Many-core algorithms for statistical phylogenetics. Bioinformatics (2009) 6.70
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst Biol (2011) 5.40
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet (2004) 5.32
Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol (2002) 5.24
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis (2008) 5.20
Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol (2004) 5.17
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol (2004) 5.08
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis (2013) 4.87
Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol (2010) 4.82
Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med (2008) 4.76
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet (2009) 4.56
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics. Bioinformatics (2011) 4.41
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS (2007) 4.40
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Adaptation of HIV-1 to human leukocyte antigen class I. Nature (2009) 4.24
Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol Biol Evol (2012) 4.16
Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infect Genet Evol (2007) 4.11
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol (2009) 4.10
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem (2003) 4.03
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev (2007) 3.96
Global distribution and prevalence of hepatitis C virus genotypes. Hepatology (2014) 3.95
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS (2007) 3.94
Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem (2005) 3.75
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med (2008) 3.67
Gain-of-function experiments on H7N9. Science (2013) 3.67
Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis (2003) 3.66
Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med (2008) 3.66
2011 update of the drug resistance mutations in HIV-1. Top Antivir Med (2011) 3.66
MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis (2014) 3.64
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis (2011) 3.59
Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med (2013) 3.58
Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med (2009) 3.52
H5N1 outbreaks and enzootic influenza. Emerg Infect Dis (2006) 3.49
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet (2013) 3.40
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. Lancet Infect Dis (2009) 3.37
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med (2005) 3.17
Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials. Clin Infect Dis (2008) 3.15
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14
Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.10
Influenza-associated hospitalization in a subtropical city. PLoS Med (2006) 3.07
Accommodating the effect of ancient DNA damage on inferences of demographic histories. Mol Biol Evol (2008) 3.07
Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med (2006) 3.06
Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. Proc Natl Acad Sci U S A (2005) 3.04
Inferring confidence sets of possibly misspecified gene trees. Proc Biol Sci (2002) 2.98
Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol (2002) 2.97
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog (2009) 2.92
Update of the Drug Resistance Mutations in HIV-1. Top HIV Med (2008) 2.91
Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med (2010) 2.91
Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology (2010) 2.90
The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A (2007) 2.89
Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med (2007) 2.79
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76
Gene3D: comprehensive structural and functional annotation of genomes. Nucleic Acids Res (2007) 2.75
Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry (2005) 2.74
A Bayesian phylogenetic method to estimate unknown sequence ages. Mol Biol Evol (2010) 2.73
U.S. Human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains. J Virol (2003) 2.64